Changing Minds, Massive Market

In this chapter, Ben and David discuss the potential commercial opportunity of a weight loss drug in a market with a massive number of medically obese individuals. They explore the chronic nature of obesity and the recurring revenue potential it presents, making it unlike any other disease in the pharma industry.